Central nervous system pH in uremia and the effects of hemodialysis
- PMID: 8469
- PMCID: PMC333184
- DOI: 10.1172/JCI108473
Central nervous system pH in uremia and the effects of hemodialysis
Abstract
Rapid hemodialysis of uremic animals may induce a syndrome characterized by increased cerebrospinal fluid (CSF) pressure, grand mal seizures, and electroencephalographic abnormalities. There is a fall in pH and bicarbonate concentration in CSF, and brain osmolality exceeds that of plasma, resulting in a net movement of water into the brain. This syndrome has been called experimental dialysis disequilibrium syndrome. The fall in pH of CSF may be secondary to a fall of intracellular pH (pHi) in brain. Since changes in pHi can alter intracellular osmolality in other tissues, it was decided to investigate brain pHi in uremia, and the effects of hemodialysis. Brain pHi was measured by evaluating the distribution of 14C-labeled dimethadione in brain relative to CSF, while extracellular space was calculated as the 35504=/4 space relative to CSF. In animals with acute renal failure, brain (cerebral cortex) pHi was 7.06+/-0.02 (+/-SE) while that in CSF was 7.31+/-0.02, both values not different from normal. After rapid hemodialysis (100 min) of uremic animals, plasma creatinine fell from 11.8 to 5.9 mg/dl. Brain pHi was 6.89+/-0.02 and CSF pH and 7.19+/-0.02, both values significantly lower than in uremic animals (P less than 0.01), and there was a 12% increase in brain water content. After slow hemodialysis (210 min), brain pHi (7.01+/-0.02) and pH in CSF (7.27+/-0.02) were both significantly greater than values observed after rapid hemodialysis (P less than 0.01), and brain water content was normal. None of the above maneuvers had any effect on pHi of skeletal muscle or subcortical white matter. The data show that rapid hemodialysis of uremic dogs is accompanied by a significant fall in pH of CSF and pHi in cerebral cortex. Accompanying the fall in brain pHi is cerebral edema.
Similar articles
-
Muscle water and electrolytes in uremia and the effects of hemodialysis.J Lab Clin Med. 1977 Feb;89(2):322-31. J Lab Clin Med. 1977. PMID: 833470
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Acute cerebral and pulmonary edema induced by hemodialysis.Chin Med J (Engl). 2008 Jun 5;121(11):1003-9. Chin Med J (Engl). 2008. PMID: 18706248
-
Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes.J Clin Invest. 1975 Apr;55(4):738-45. doi: 10.1172/JCI107984. J Clin Invest. 1975. PMID: 235562 Free PMC article.
-
Does uremia protect against the demyelination associated with correction of hyponatremia during hemodialysis? A case report and literature review.Semin Dial. 2003 Jan-Feb;16(1):68-71. doi: 10.1046/j.1525-139x.2003.03015.x. Semin Dial. 2003. PMID: 12535304 Review.
Cited by
-
Research progress on the kidney-gut-brain axis in brain dysfunction in maintenance hemodialysis patients.Front Med (Lausanne). 2025 Mar 6;12:1538048. doi: 10.3389/fmed.2025.1538048. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40115780 Free PMC article. Review.
-
Dialysis disequilibrium syndrome: A case report.SAGE Open Med Case Rep. 2024 Aug 16;12:2050313X241266445. doi: 10.1177/2050313X241266445. eCollection 2024. SAGE Open Med Case Rep. 2024. PMID: 39161917 Free PMC article.
-
Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging.J Clin Invest. 1996 Aug 1;98(3):750-5. doi: 10.1172/JCI118847. J Clin Invest. 1996. PMID: 8698867 Free PMC article.
-
Dialysis disequilibrium syndrome.Pediatr Nephrol. 2012 Dec;27(12):2205-11. doi: 10.1007/s00467-012-2199-4. Epub 2012 Jun 19. Pediatr Nephrol. 2012. PMID: 22710692 Free PMC article. Review.
-
Therapeutic hypernatremia management during continuous renal replacement therapy with elevated intracranial pressures and respiratory failure.Rev Endocr Metab Disord. 2019 Mar;20(1):65-75. doi: 10.1007/s11154-019-09483-2. Rev Endocr Metab Disord. 2019. PMID: 30848433 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials